Description
Nitazoxanide is an antiprotozoal medication used for the treatment of diarrhoea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 years of age and older.
- Limitations of Use:
- Ineffective for treating diarrhea caused by C. parvum in HIV-infected or immunodeficient patients.
Dosage and Side Effects
Pediatric patients who are 11 years of age or younger should not receive the Nitazoxanide tablet since one tablet contains more nitazoxanide than is advised for this age group.
- For patients 1-3 years old, 100 mg of nitazoxanide administered orally every 12 hours with food is the suggested dosage.
- For patients ages 4 to 11, 200 mg of nitazoxanide administered orally every 12 hours with food is the suggested dosage.
- For patients, twelve years of age and above, 500 mg of nitazoxanide administered orally every twelve hours with food is the suggested dosage.
Nitazoxanide 500 mg and 200 mg side effects that are frequently mentioned include headache, nausea, chromaturia, and abdominal pain.
FAQ's
What are Nitazoxanide Tablets used for?
Nitazoxanide Tablets are indicated for treating diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients aged 12 years and older.
What is the recommended dosage of Nitazoxanide Tablets?
For patients aged 12 years and older, the recommended dosage is 500 mg orally every 12 hours with food for 3 days.
Who should avoid taking Nitazoxanide Tablets?
Pediatric patients aged 11 years or younger should not be administered Nitazoxanide Tablets. Additionally, it has not been proven effective for treating diarrhea caused by C. parvum in HIV-infected or immunodeficient patients.
What are the common side effects associated with Nitazoxanide Tablets?
The most common adverse reactions reported in at least 2% of patients include abdominal pain, headache, chromaturia (colouration of urine), and nausea.
Are there any limitations or contraindications for using Nitazoxanide Tablets?
Nitazoxanide 200 mg Tablets are contraindicated in individuals with known hypersensitivity to the medication. It should also be noted that its efficacy hasn’t been demonstrated for certain groups, such as HIV-infected or immunodeficient patients.